Key Sessions
Sarah Snykers
Transforming Cell Therapy Manufacturing: Legend's Journey from Start Up to Commercial Manufacturing and Beyond
Legend Biotech
Rutger Douma
Establishing a Network to Produce Lentiviral Vectors for Carvykti®
Johnson & Johnson Innovative Medicine
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Showing 1 of 1 Streams
Registration
08:00 - 08:55
Registration & Coffee
Showing 1 of 1 Streams
Keynote Plenary
08:55 - 09:00
Welcome to Cell & Gene Therapy International Europe
09:00 - 09:10
Chairperson’s Opening Remarks
09:10 - 09:50
Keynote: In Vivo CAR-T Therapies from Concept to Reality: Product Development and Clinical Advances
09:50 - 10:30
Keynote Investor Panel: Funding the Future- Investment Trends and Opportunities for Cell and Gene Therapies and Enabling Technologies
- Bo Wiinberg - Chief Business Development Officer, Novo Nordisk Foundation Cellerator
- Artemy Shumskiy - Principal, LongeVC
- Christian Kannemeier - Senior Investment Manager, High-Tech Gründerfonds Management GmbH
Showing 1 of 1 Streams
Break
10:30 - 11:10
Morning Coffee and Networking Break in Exhibition Hall
Showing 2 of 2 Streams
Cell Therapy Manufacturing & Analytics
Gene Therapy Manufacturing & Analytics
11:10 - 11:15
Chairperson’s Opening Remarks: Cell Therapy Manufacturing & Analytics
11:15 - 11:45
Transforming Cell Therapy Manufacturing: Legend's Journey from Start Up to Commercial Manufacturing and Beyond
- Sarah Snykers - Head of Site Strategy & Excellence, Legend Biotech
11:45 - 12:15
Case Study: Cell Therapy Manufacturing Scale Up from Clinical to Commercial
- Ketki Vispute - MSAT Associate Director, Autolus
12:15 - 12:45
Sponsored Scientific Track Presentation
11:10 - 11:15
Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics
11:15 - 11:45
Keynote Panel Discussion: Pioneering Gene Therapy Manufacturing: Tackling Bottlenecks to Scale, Boost Potency, Quality and Lower Costs Per Dose
11:45 - 12:15
Establishing a Network to Produce Lentiviral Vectors for Carvykti®
- Rutger Douma - MSAT Advanced Therapies Director, Johnson & Johnson Innovative Medicine
12:15 - 12:45
Sponsored Scientific Track Presentation: Implementation of Single Use Technologies for Gene Therapy Manufacturing
Showing 2 of 2 Streams
Break
Live Labs Tour in Exhibition Hall
Live Labs 12:45 - 14:00
Networking Lunch in the Exhibition Hall
12:45 - 13:10Live Labs
Networking Lunch in the Exhibition Hall
13:10 - 13:50Live Labs
Live Labs Tour in Exhibition Hall
Gain an insight into some of the most cutting- edge technology and services hitting today’s Cell & Gene Therapies market through a series of 10-minute product demos live at the exhibit booths.
If you are interested in presenting your technology or service as part of the live lab tour please contact Roshni Shah – Roshni.shah@informa.com for more information.
13:50 - 14:00Live Labs
Networking Lunch in the Exhibition Hall
Showing 2 of 2 Streams
Cell Therapy Manufacturing & Analytics
Gene Therapy Manufacturing & Analytics
14:00 - 14:30
Quality by Design in Cell Therapy Manufacturing – Implementation of Process Improvements
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
14:30 - 15:00
Balancing Personalisation & Scalability in TCR-T Cell Therapies to Scale the Modality
- Anette Brass - Head of Process Development, Anocca AB
15:00 - 15:30
Sponsored Scientific Track Presentation
14:00 - 14:30
Upstream Innovation to Improve Product Quality and Increase Cell Density in Scalable AAV Production
- Clotilde Ciesla - Upstream Development Engineer, Genethon
14:30 - 15:00
Case Study from VectorY: Revolutionising Large Scale Gene Therapy Production
- Pranav Puri - Head BioProcess Development, VectorY
15:00 - 15:30
Sponsored Scientific Track Presentation
Showing 1 of 1 Streams
Break
15:30 - 16:15
Afternoon Coffee and Networking Break in Exhibition Hall
Showing 2 of 2 Streams
Cell Therapy Manufacturing & Analytics
Gene Therapy Manufacturing & Analytics
16:15 - 16:45
Closing the Loop: Practical Steps for Implementing Closed Systems at Scale
16:45 - 17:15
End to End Workflow Automation in Cell Therapy Manufacturing: Strategies for Implementation at Scale
16:15 - 16:45
Maximising Capsid Recovery: Optimising Downstream Processing for Higher Yields
- Parag Kumthekar - Lead Gene Therapy Downstream Process Development, UCB
16:45 - 17:15
Case Study: Cost Reduction Innovations in Downstream Processing for AAVs
17:15 - 18:30
Networking Drinks Reception in the Exhibition Hall
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
